Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

Wyeth

Status and phase: Terminated; Phase 3; Phase 2

Conditions: Fibromyalgia

Treatments: Drug: DVS-233

Study type: Interventional

Funder types: Industry

Identifiers

NCT00301431

3151A4-327

Details and patient eligibility

About

The purpose of this study is to determine if DVS-233 is safe and effective in the treatment of pain and other symptoms of fibromyalgia syndrome.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Fibromyalgia according to 1990 American College of Rheumatology (ACR) criteria

Exclusion criteria

• Other painful conditions that may make results difficult to interpret.
• Treatment with other drugs for fibromyalgia with 14 days of study start or during the study.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind